AU1980197A - Il-13 binding chain of il-13 receptor - Google Patents

Il-13 binding chain of il-13 receptor

Info

Publication number
AU1980197A
AU1980197A AU19801/97A AU1980197A AU1980197A AU 1980197 A AU1980197 A AU 1980197A AU 19801/97 A AU19801/97 A AU 19801/97A AU 1980197 A AU1980197 A AU 1980197A AU 1980197 A AU1980197 A AU 1980197A
Authority
AU
Australia
Prior art keywords
receptor
binding chain
binding
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU19801/97A
Inventor
Mary Collins
Debra Donaldson
Lori Fitz
Tamlyn Neben
Matthew Whitters
Clive Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24441355&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU1980197(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Publication of AU1980197A publication Critical patent/AU1980197A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU19801/97A 1996-03-01 1997-02-28 Il-13 binding chain of il-13 receptor Abandoned AU1980197A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/609,572 US5710023A (en) 1996-03-01 1996-03-01 IL-13 cytokine receptor chain
US08609572 1996-03-01
PCT/US1997/003124 WO1997031946A1 (en) 1996-03-01 1997-02-28 Il-13 binding chain of il-13 receptor

Publications (1)

Publication Number Publication Date
AU1980197A true AU1980197A (en) 1997-09-16

Family

ID=24441355

Family Applications (1)

Application Number Title Priority Date Filing Date
AU19801/97A Abandoned AU1980197A (en) 1996-03-01 1997-02-28 Il-13 binding chain of il-13 receptor

Country Status (3)

Country Link
US (5) US5710023A (en)
AU (1) AU1980197A (en)
WO (1) WO1997031946A1 (en)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742156A1 (en) * 1995-12-06 1997-06-13 Sanofi Sa IL-13 RECEPTOR POLYPEPTIDE
US6664227B1 (en) 1996-03-01 2003-12-16 Genetics Institute, Llc Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
US20030100046A1 (en) * 1996-03-13 2003-05-29 James W. Baumgartner Testis-specific receptor
EP0812913A3 (en) * 1996-06-12 1999-08-04 Smithkline Beecham Corporation HR-1 receptor, a receptor of the cytokine receptors family
US6743604B1 (en) 1996-12-13 2004-06-01 Smithkline Beecham Corporation Substances and their uses
GB9625899D0 (en) * 1996-12-13 1997-01-29 Glaxo Group Ltd Substances and their uses
AU2226799A (en) * 1998-01-15 1999-08-02 Center For Molecular Medicine And Immunology Antibody/receptor targeting moiety for enhanced delivery of armed ligand
US6703488B1 (en) 1998-01-15 2004-03-09 Center For Molecular Medicine And Immunology Antibody/receptor targeting moiety for enhanced delivery of armed ligand
US6057128A (en) 1998-03-17 2000-05-02 Genetics Institute, Inc. MU-1, member of the cytokine receptor family
US7198789B2 (en) 1998-03-17 2007-04-03 Genetics Institute, Llc Methods and compositions for modulating interleukin-21 receptor activity
US7189400B2 (en) 1998-03-17 2007-03-13 Genetics Institute, Llc Methods of treatment with antagonists of MU-1
AU5297299A (en) * 1998-08-17 2000-03-06 Patrick T. Prendergast Cytokine and cytokine receptor, agonist, antagonist and/or antibody combination for therapeutic use
US7083949B2 (en) 1998-09-25 2006-08-01 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
US6472179B2 (en) * 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
US6927044B2 (en) 1998-09-25 2005-08-09 Regeneron Pharmaceuticals, Inc. IL-1 receptor based cytokine traps
NZ512942A (en) 1998-12-14 2004-01-30 Univ Johns Hopkins Polynucleotides encoding the IL-13 binding chains of the interleukin receptor, pharmaceutical compositions comprising the protein and methods of identifying inhibitors
AU2005202229B2 (en) * 1998-12-14 2006-11-16 Genetics Institute, Llc Cytokine Receptor Chain
US7553487B2 (en) * 1998-12-14 2009-06-30 Genetics Institute, Llc Method and compositions for treating asthma
US6468528B1 (en) * 1999-02-01 2002-10-22 Amgen Canada Inc. Materials and methods to inhibit Hodgkin and Reed Sternberg cell growth
CA2404763A1 (en) * 1999-11-11 2001-05-17 Raj K. Puri Mutated il-13 molecules and their uses
US20020197266A1 (en) * 2000-02-08 2002-12-26 Waldemar Debinski Immunotherapy using interleukin 13 receptor subunit alpha 2
AU2001253282A1 (en) * 2000-04-07 2001-10-23 Heska Corporation Compositions and methods related to canine igg and canine il-13 receptors
DK2990420T3 (en) 2000-05-26 2017-04-03 Immunex Corp USE OF INTERLEUKIN-4 RECEPTOR ANTIBODIES AND COMPOSITIONS THEREOF
EP1402451A4 (en) * 2001-06-07 2005-01-05 Wyeth Corp Solution structure of il-13 and uses thereof
CA2486106C (en) 2002-05-16 2013-07-16 Glycomimetics, Inc. Compounds and methods for inhibiting selectin-mediated function
US20070104710A1 (en) * 2002-06-28 2007-05-10 Domants Limited Ligand that has binding specificity for IL-4 and/or IL-13
JP2006502986A (en) * 2002-07-03 2006-01-26 グリコミメティクス， インコーポレイテッド Compositions and methods for diagnosis and treatment of medical conditions involved in angiogenesis
CN1688340A (en) 2002-07-15 2005-10-26 韦思公司 Methods and compositions for modulating T helper (TH) cell development and function
US20110223168A1 (en) * 2002-12-27 2011-09-15 Greg Winter Ligand that has binding specificity for il-4 and/or il-13
EP1444989A1 (en) * 2003-02-07 2004-08-11 Giorgio Dr. Stassi Sensitizing cells for apoptosis by selectively blocking cytokines
US20040174043A1 (en) * 2003-03-06 2004-09-09 Ross Bradsen Motorized rack and pinion assembly
US20040219158A1 (en) * 2003-05-02 2004-11-04 Glycomimetics, Inc. Compositions and methods for diagnosis and therapy of medical conditions involving infection with pseudomonas bacteria
WO2005051920A2 (en) * 2003-11-19 2005-06-09 Glycomimetics, Inc. Specific antagonist for both e- and p-selectins
JP2007524658A (en) * 2003-11-19 2007-08-30 グリコミメティクス， インコーポレイテッド Glucose mimetic antagonists for both E- and P-selectin
EP1703893B1 (en) * 2003-12-23 2012-04-11 Genentech, Inc. Novel anti-il 13 antibodies and uses thereof
JP2007522246A (en) * 2004-02-12 2007-08-09 ネクター セラピューティクス Interleukin-13 antagonist powder, spray-dried particles, and method
AR049390A1 (en) * 2004-06-09 2006-07-26 Wyeth Corp ANTIBODIES AGAINST HUMAN INTERLEUQUINE-13 AND USES OF THE SAME
US20090098142A1 (en) * 2004-06-09 2009-04-16 Kasaian Marion T Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
US7501121B2 (en) * 2004-06-17 2009-03-10 Wyeth IL-13 binding agents
US8201377B2 (en) * 2004-11-05 2012-06-19 Faus Group, Inc. Flooring system having multiple alignment points
EP1824886B1 (en) 2004-11-17 2010-12-22 Amgen Inc. Fully human monoclonal antibodies to il-13
US20080044420A1 (en) * 2005-05-11 2008-02-21 Heavner George A Anti-IL-13 antibodies, compositions, methods and uses
WO2006127906A1 (en) * 2005-05-25 2006-11-30 Glycomimetics, Inc. Heterobifunctional compounds for selectin inhibition
AU2006280101B2 (en) * 2005-08-09 2012-06-28 Glycomimetics, Inc. Glycomimetic inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from Pseudomonas
AU2006284578B2 (en) 2005-09-02 2011-01-27 Glycomimetics, Inc. Heterobifunctional pan-selectin inhibitors
US7495097B2 (en) * 2005-11-23 2009-02-24 Brown University Rhodium quinonoid catalysts
TW200806317A (en) * 2006-03-20 2008-02-01 Wyeth Corp Methods for reducing protein aggregation
WO2007143052A1 (en) * 2006-06-01 2007-12-13 Glycomimetics, Inc. Galactosides and thiodigalactosides as inhibitors of pa-il lectin from pseudomonas
DK2041576T3 (en) * 2006-06-21 2011-12-05 Apogenix Gmbh Differential cytokine expression in human cancers
EP2049147A2 (en) * 2006-07-06 2009-04-22 Apogenix GmbH Human il-4 muteins in combination with chemotherapeutics or pro-apoptotic agents in cancer therapy
JP5298020B2 (en) 2006-10-12 2013-09-25 グリコミメティクス， インコーポレイテッド Glucose mimic substitution of hexose and N-acetylhexosamine
JP5511390B2 (en) * 2007-02-09 2014-06-04 グリコミメティクス， インコーポレイテッド Method of using a sugar mimetic having a hexose and N-acetylhexosamine substitution
EP2137215A2 (en) * 2007-04-23 2009-12-30 Wyeth Methods and compositions for treating and monitoring treatment of il-13-associated disorders
TW200902708A (en) * 2007-04-23 2009-01-16 Wyeth Corp Methods of protein production using anti-senescence compounds
US8039442B2 (en) 2007-07-18 2011-10-18 Glycomimetics, Inc. Compounds and methods for treatment of sickle cell disease or complications associated therewith
WO2009126556A1 (en) 2008-04-08 2009-10-15 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
ES2426784T3 (en) * 2008-06-13 2013-10-25 Glycomimetics, Inc. Treatment of blood cancers using selected glyomimetic compounds
NZ591098A (en) 2008-08-20 2012-08-31 Centocor Ortho Biotech Inc Engineered anti-il-13 antibodies, compositions, methods and uses
WO2010121125A1 (en) 2009-04-17 2010-10-21 Wake Forest University Health Sciences Il-13 receptor binding peptides
CA2760292A1 (en) * 2009-05-01 2010-11-04 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
WO2012037034A1 (en) 2010-09-14 2012-03-22 Glycomimetics, Inc. E-selectin antagonists
JP2015500887A (en) 2011-12-22 2015-01-08 グリコミメティクス， インコーポレイテッド E-selectin antagonist compounds, compositions and methods of use
AU2013355238B2 (en) 2012-12-07 2017-12-14 Glycomimetics, Inc. Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cells
KR102332302B1 (en) 2013-09-13 2021-12-01 제넨테크, 인크. Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products
CA3184564A1 (en) 2013-09-13 2015-03-19 Genentech, Inc. Methods and compositions comprising an anti-il13 antibody and residual hamster phospholipase b-like 2
SI3227310T1 (en) 2014-12-03 2019-11-29 Glycomimetics Inc Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
CA3009836A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
US11291678B2 (en) 2016-03-02 2022-04-05 Glycomimetics, Inc Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
US20190086392A1 (en) 2016-03-21 2019-03-21 Inserm (Institut National De La Sante Et De La Recherch Medicale) Methods for diagnosis and treatment of solar lentigo
WO2018031445A1 (en) 2016-08-08 2018-02-15 Glycomimetics, Inc. Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4
JP7069136B2 (en) 2016-10-07 2022-05-17 グリコミメティクス， インコーポレイテッド Extremely potent multimeric E-selectin antagonist
EP3596096A1 (en) 2017-03-15 2020-01-22 GlycoMimetics, Inc. Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
JP7275131B2 (en) 2017-11-30 2023-05-17 グリコミメティクス， インコーポレイテッド Methods of mobilizing bone marrow-infiltrating lymphocytes and uses thereof
CN111566117A (en) 2017-12-29 2020-08-21 糖模拟物有限公司 Heterobifunctional inhibitors of E-selectin and galectin-3
JP7455064B2 (en) 2018-03-05 2024-03-25 グリコミメティクス， インコーポレイテッド Methods of treating acute myeloid leukemia and related conditions
WO2020139962A1 (en) 2018-12-27 2020-07-02 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011912A (en) * 1986-12-19 1991-04-30 Immunex Corporation Hybridoma and monoclonal antibody for use in an immunoaffinity purification system
AU643427B2 (en) * 1988-10-31 1993-11-18 Immunex Corporation Interleukin-4 receptors
US5246701A (en) * 1990-10-05 1993-09-21 Ludwig Institute For Cancer Research Method for inhibiting production of IgE by using IL-9 inhibitors
JPH07508179A (en) * 1992-08-21 1995-09-14 シェリング・コーポレーション human interleukin-13
US5696234A (en) * 1994-08-01 1997-12-09 Schering Corporation Muteins of mammalian cytokine interleukin-13
AU718899C (en) 1995-10-23 2004-01-29 Amrad Operations Pty. Limited A novel haemopoietin receptor and genetic sequences encoding same
FR2742156A1 (en) 1995-12-06 1997-06-13 Sanofi Sa IL-13 RECEPTOR POLYPEPTIDE
AU2326097A (en) 1996-03-13 1997-10-01 Zymogenetics Inc. Cytokine-receptor expressed in testis cells
US20030100046A1 (en) * 1996-03-13 2003-05-29 James W. Baumgartner Testis-specific receptor

Also Published As

Publication number Publication date
US6268480B1 (en) 2001-07-31
US6214559B1 (en) 2001-04-10
US7674591B2 (en) 2010-03-09
US20060177902A1 (en) 2006-08-10
US5710023A (en) 1998-01-20
US6248714B1 (en) 2001-06-19
WO1997031946A1 (en) 1997-09-04

Similar Documents

Publication Publication Date Title
AU1980197A (en) Il-13 binding chain of il-13 receptor
AU5539196A (en) Adaptive binding
IL175399A (en) Antibodies binding to ob receptor variants
AU5587898A (en) Snowboard binding
AU7576096A (en) Il-13 receptor polypeptide
AU1704697A (en) Leptin receptor variants
AU8466498A (en) Ski binding
AU5456698A (en) Binding agents specific for iga receptor
AU1698897A (en) Leptin receptor variants
AU5178696A (en) Snowboard binding assembly
AU3668797A (en) Cytokine receptor signal transduction chain
AU4051797A (en) Snowboard binding
AU7132898A (en) Edg-1-like receptor
AU2664797A (en) Wnt receptor compositions and methods
AU6748196A (en) Receptor
GB9617923D0 (en) Novel receptor
AU6692598A (en) Growth factor receptor binding protein
AU2194997A (en) Snowboard binding
EP0724899A3 (en) Ski binding
AU8465798A (en) Novel pectin
AUPO938697A0 (en) Novel receptor
AU6035398A (en) Human c5a-like receptor
AU4586497A (en) Calcium-integrin binding protein
AU6775496A (en) Novel human g-protein coupled receptor
AU9229498A (en) Human sigma receptor